Furthermore, there was study observed a novel functional role of CEA in promoting endothelial cell activation and subsequent tumor angiogenesis, indicating that increasing CEA can antagonize the anti-angiogenesis effect of bevacizumab and be a cause for the failure of the bevacizumab-based maintenance therapy [17]. Here, CEACAM5 is linked to neoplasm.